Appendix 3H - Notification of cessation of securities Announcement Summary Entity name THE HYDRATION PHARMACEUTICALS COMPANY LIMITED Announcement Type New announcement Date of this announcement Tuesday November 10, 2026 Details of +securities that have ceased Number of ASX +security +securities...
Notification of cessation of securities - HPC
Filed with ASX · · 5 pages · English
Summary by 6ix AI
Hydration Pharmaceuticals Company Limited has filed a notification regarding the cessation of certain securities, specifically warrants that have expired without exercise or conversion. Following this cessation, the company's issued capital will include various classes of equity and debt securities. This announcement serves to inform the market about the changes in the company's securities status.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Hydration Pharmaceuticals Company Limited on 6ix
In the deck
Earlier from Hydration Pharmaceuticals
- Rights Offer - Despatch of Prospectus
- Q3 FY26 Quarterly Activities Report (App 4C)
- Becoming a substantial holder
- Change in substantial holding
- Proposed issue of securities - HPC
Later from Hydration Pharmaceuticals
- Change of Director's Interest Notice
- Investor Presentation
- Update - Proposed issue of securities - HPC
- Extension of Rights Issue Closing Date
Follow Hydration Pharmaceuticals into a list and get an email when it puts out news.
Follow Hydration Pharmaceuticals